Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes and, more recently, some have been approved for weight management
These approaches work best as complements to medical treatment, not replacements
Adding 2 mL of bacteriostatic water creates a concentration of 5 mg per mL
Well-designed clinical trials with depression as a primary outcome measure are needed to establish whether GLP-1 agonists have genuine antidepressant properties independent of their metabolic effects
The difference between drawing 4 units and 8 units on your syringe for the same dose
Calorie Deficit: What to Know Doherty, R., Madigan, S., Nevill, A., Warrington, G., & Ellis, J